Capnography Equipment Market worth $0.87 billion by 2031 - Exclusive Report by MarketsandMarkets™

MarketsandMarkets projects the global capnography equipment market will grow from USD 0.67 billion in 2026 to USD 0.87 billion by 2031, a 5.5% CAGR. North America held 42.7% of the market in 2025, while accessories and disposables accounted for 53.8%; growth drivers cited include increased monitoring needs, surgical procedures, and adoption in critical care. The article also cites TidalSense’s USD 19 million funding in July 2026 and discusses portable, AI-enabled monitoring and prior sector acquisitions.

Analysis

The forecast is a weak standalone earnings catalyst: the projected market remains small relative to the diversified businesses of GE HealthCare (GEHC), Medtronic (MDT), Philips (PHG), and ICU Medical (ICUI), and it is a third-party estimate rather than company guidance. The more investable mechanism is consumables pull-through: installed monitors can create repeat demand, but the benefit accrues only where vendors retain the account and consumable choice is not easily substituted. Integrated monitoring platforms may have a distribution and workflow advantage; portable devices and waveform software could instead shift value toward lower-cost entrants or make hardware less differentiated. Neither outcome is established by this release.

Near term, expect little durable share-price impact. Over 1–3 months, look for earnings commentary on monitoring placements, disposable utilization, pricing, and hospital procurement. Over 6–18 months, adoption in sedation, emergency care, and outpatient settings could support recurring revenue, but reimbursement, clinical workflow, and budget constraints may slow conversion. The report offers no company-level revenue exposure or adoption data; do not translate its market CAGR into issuer growth. A reversal signal would be flat/down monitoring orders or consumables, price pressure, or management indicating delayed hospital capital spending.

Key Decisions for Investors

• No broad sector trade on this release. Treat the forecast as a watchlist input, not a basis for revising earnings estimates or paying a higher multiple for GEHC, MDT, PHG, or ICUI.
• At the next earnings updates, monitor capnography-specific placements, consumables growth/pricing, and any evidence of attach rates in procedural sedation and emergency care. Favor issuers only if they provide measurable evidence of recurring pull-through; verify that figures are not aggregated with broader monitoring businesses.
• Revisit a relative-value position only if company disclosures show materially different capnography growth or disposable economics. Falsify the positive adoption thesis if orders or consumables weaken, pricing erodes, or hospital spending delays persist; no exposure estimate or valuation case in the article supports a price target today.